EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine.
Recruiting
Observational Study
Migraine Disorders
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- IRCCS San Raffaele Roma · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The object of this study is to assess the effectiveness, safety, and tolerability of eptinezumab in a real life migraine population.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
KEY INCLUSION CRITERIA
1. Age between 18 and 75 years;
2. Males and females;
3. Willingness to sign the informed consent;
4. High frequency episodic migraine, at least 8 days per month of disabling migraine in the past 3 months;
5. Chronic migraine, according to the ICHD-III criteria;
KEY EXCLUSIO…
Contacts